Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K W Mahaffey

Showing results (11-20 of 28) with videos related to

Pageof 3
Sort By:
Journal of the American College of Cardiology|November 13, 2001
A randomized, placebo-controlled trial of enoxaparin after high-risk coronary stenting: the ATLAST trialW B Batchelor, K W Mahaffey, P B Berger, et al.
Emergency Medicine Journal : EMJ|July 29, 2008
Initial risk stratification and presenting characteristics of patients with evolving myocardial infarctionsC D Miller, G J Fermann, C J Lindsell, et al.
Diabetes, Obesity & Metabolism|October 10, 2015
Efficacy and safety of canagliflozin when used in conjunction with incretin-mimetic therapy in patients with type 2 diabetesG Fulcher, D R Matthews, V Perkovic, et al.
Journal of Clinical Pharmacology|March 27, 2014
Population pharmacokinetics and pharmacodynamics of rivaroxaban in patients with non-valvular atrial fibrillation: results from ROCKET AFI G Girgis, M R Patel, G R Peters, et al.
Circulation|March 14, 1998
Risk factors for in-hospital nonhemorrhagic stroke in patients with acute myocardial infarction treated with thrombolysis: results from GUSTO-IK W Mahaffey, C B Granger, M A Sloan, et al.
American Heart Journal|September 1, 1999
Neurosurgical evacuation of intracranial hemorrhage after thrombolytic therapy for acute myocardial infarction: experience from the GUSTO-I trial. Global Utilization of Streptokinase and tissue-plasminogen activator (tPA) for Occluded Coronary ArteriesK W Mahaffey, C B Granger, M A Sloan, et al.
European Heart Journal|February 10, 2000
Geographic variability in outcomes within an international trial of glycoprotein IIb/IIIa inhibition in patients with acute coronary syndromes. Results from PURSUITK M Akkerhuis, J W Deckers, E Boersma, et al.
Stroke|March 20, 1998
Thrombolysis-related intracranial hemorrhage: a radiographic analysis of 244 cases from the GUSTO-1 trial with clinical correlation. Global Utilization of Streptokinase and Tissue Plasminogen Activator for Occluded Coronary ArteriesJ M Gebel, C A Sila, M A Sloan, et al.
Journal of the American College of Cardiology|February 6, 1999
Clinical outcomes after detection of elevated cardiac enzymes in patients undergoing percutaneous intervention. IMPACT-II Investigators. Integrilin (eptifibatide) to Minimize Platelet Aggregation and Coronary Thrombosis-IIB E Tardiff, R M Califf, J E Tcheng, et al.
Circulation|October 7, 1998
Prediction of 30-day mortality among patients with thrombolysis-related intracranial hemorrhageM A Sloan, C A Sila, K W Mahaffey, et al.
Pageof 3

Showing results (11-20 of 28) with videos related to

Sort By:
Pageof 3
Journal of the American College of Cardiology|November 13, 2001
A randomized, placebo-controlled trial of enoxaparin after high-risk coronary stenting: the ATLAST trialW B Batchelor, K W Mahaffey, P B Berger, et al.
Emergency Medicine Journal : EMJ|July 29, 2008
Initial risk stratification and presenting characteristics of patients with evolving myocardial infarctionsC D Miller, G J Fermann, C J Lindsell, et al.
Diabetes, Obesity & Metabolism|October 10, 2015
Efficacy and safety of canagliflozin when used in conjunction with incretin-mimetic therapy in patients with type 2 diabetesG Fulcher, D R Matthews, V Perkovic, et al.
Journal of Clinical Pharmacology|March 27, 2014
Population pharmacokinetics and pharmacodynamics of rivaroxaban in patients with non-valvular atrial fibrillation: results from ROCKET AFI G Girgis, M R Patel, G R Peters, et al.
Circulation|March 14, 1998
Risk factors for in-hospital nonhemorrhagic stroke in patients with acute myocardial infarction treated with thrombolysis: results from GUSTO-IK W Mahaffey, C B Granger, M A Sloan, et al.
American Heart Journal|September 1, 1999
Neurosurgical evacuation of intracranial hemorrhage after thrombolytic therapy for acute myocardial infarction: experience from the GUSTO-I trial. Global Utilization of Streptokinase and tissue-plasminogen activator (tPA) for Occluded Coronary ArteriesK W Mahaffey, C B Granger, M A Sloan, et al.
European Heart Journal|February 10, 2000
Geographic variability in outcomes within an international trial of glycoprotein IIb/IIIa inhibition in patients with acute coronary syndromes. Results from PURSUITK M Akkerhuis, J W Deckers, E Boersma, et al.
Stroke|March 20, 1998
Thrombolysis-related intracranial hemorrhage: a radiographic analysis of 244 cases from the GUSTO-1 trial with clinical correlation. Global Utilization of Streptokinase and Tissue Plasminogen Activator for Occluded Coronary ArteriesJ M Gebel, C A Sila, M A Sloan, et al.
Journal of the American College of Cardiology|February 6, 1999
Clinical outcomes after detection of elevated cardiac enzymes in patients undergoing percutaneous intervention. IMPACT-II Investigators. Integrilin (eptifibatide) to Minimize Platelet Aggregation and Coronary Thrombosis-IIB E Tardiff, R M Califf, J E Tcheng, et al.
Circulation|October 7, 1998
Prediction of 30-day mortality among patients with thrombolysis-related intracranial hemorrhageM A Sloan, C A Sila, K W Mahaffey, et al.
Pageof 3